Mu receptors raise blood glucose and cortisol, delta receptors raise fatty acids only, and kappa receptors raise glucose only — each opioid receptor type controls distinct metabolic outputs.
Receptor-specific metabolic controlMu, delta, and kappa opioid receptors each control distinct metabolic outputs when activated in the brain
What the researchers found
Mu receptor agonists raised blood glucose and corticosterone. Delta agonist raised fatty acids only. Kappa agonist raised glucose only. Mu antagonist blocked the glucose/corticosterone effects.
Why it matters
This study maps out how different brain opioid receptors control metabolism. The mu receptor's ability to raise blood sugar and stress hormones has implications for understanding opioid drug side effects and stress responses.
How the study worked
Unanesthetized rats with chronic brain cannulas received third ventricle injections of four opioid agonists at multiple doses. Blood was sampled from the tail at 0, 15, 30, 60, 90, and 120 minutes.
What this study cannot tell us
Animal study in rats using direct brain injections. The doses and route do not reflect normal physiology or clinical opioid use. Anesthetic-free but still invasive.
How to read the evidence
Preliminary animal study with clean pharmacological dissociation across receptor types. Brain injection route limits clinical translation.
When this study was published
Published in 1991. The metabolic effects of opioid receptor subtypes have been further characterized.
The bigger picture
This receptor-specific metabolic map explains why different opioid drugs have different effects on blood sugar and stress hormones. It's relevant to managing diabetic patients on opioid therapy and understanding metabolic syndrome in chronic opioid users.
Questions still open
- Should opioid selection consider receptor-specific metabolic effects in diabetic patients?
- Do the metabolic effects of opioids contribute to weight gain in chronic users?
Common questions
Why do opioids affect blood sugar?
Is this why some opioid patients gain weight?
Read the original research
mu-receptor mediates elevated glucose and corticosterone after third ventricle injection of opioid peptides.
The American journal of physiology, 261(1 Pt 2), R70-81
Citation
Gunion, M W; Rosenthal, M J; Morley, J E; Miller, S; Zib, B; Butler, B; Moore, R D. (1991). mu-receptor mediates elevated glucose and corticosterone after third ventricle injection of opioid peptides.. The American journal of physiology, 261(1 Pt 2), R70-81.